Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 42289Generated: October 29, 2026

Water → 2-Oxo-2-(2-phenylpyrimidin-5-yl)ethyl 2-phenylacetate

https://huagongshe.com/reaction/42289

Reaction equation

Participants

RoleNameHCIDCharge
ReactantWaterHCID 962—
ReactantPhenylacetic AcidHCID 999—
ReactantCesium carbonateHCID 10796—
Reactant2-Bromo-1-(2-phenylpyrimidin-5-yl)ethanoneHCID 59252454—
SolventTetrahydrofuranHCID 8028—
Product2-Oxo-2-(2-phenylpyrimidin-5-yl)ethyl 2-phenylacetateHCID 6736111957.7%

Reaction Conditions

Temperature40 °C

Reaction Steps

To a solution consisting of phenylacetic acid (27 mg, 0.20 mmol) and cesium carbonate (117 mg, 0.360 mmol) in tetrahydrofuran (1.5 mL) at room temperature was added 2-bromo-1-(2-phenylpyrimidin-5-yl)ethanone (Step B, 50 mg, 0.18 mmol). The reaction mixture was heated at 40° C. for one hour and cooled to room temperature. To the mixture was added water (10 mL) with vigorous stirring and the precipitate was filtered, washed with water, and dried on the suction filter to provide 2-oxo-2-(2-phenylpyrimidin-5-yl)ethyl 2-phenylacetate as a tan solid (34.5 mg, 57% yield) as an isolated intermediate. The tan solid was dissolved in toluene (4 mL) and freshly prepared ammonium acetate under toluene (300 mg wet with toluene) was added and the mixture was stirred vigorously and heated in a capped vial at 112° C. overnight. The brown reaction mixture was poured into aqueous sodium bicarbonate and extracted twice with ethyl acetate. The combined organic phase was dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure to dryness. The brown solid was dissolved in dichloromethane and chromatographed on a 4 g silica column eluted with 1:4:5 to 1:6:3 dichloromethane-ethyl acetate-hexane to afford the title compound as a tan solid; Rf 0.08 with 6:4 v/v hexanes-ethyl acetate and Rf 0.61 with 3:7 v/v hexanes-ethyl acetate; melting point 235° C.; 1H-NMR (400 MHz; DMSO-d6) δ 9.21 (s, 2H), 8.3-8.5 (m, 2H), 7.82 (d, 1H), 7.5-7.6 (m, 3H), 7.2-7.4 (m, 5H), 4.08 (s, 2H); MS (ESI+) m/z 313 (M+1); H-PGDS FPBA IC50: 0.625 μM; H-PGDS inhibitor EIA IC50: 0.059 μM.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08536185B2
Source datasetuspto-grants-2013_09
ORD IDord-3b82c153793849d1b1767a4e618ea711
Source noteuspto-grants-2013_09